ProfileGDS5678 / 1431282_at
TitleAnti-VEGF and Anti-Notch treatment effect on U87 glioblastoma xenograft tumors [Mouse430_2]
OrganismMus musculus


control bevacizumab dibenzazepine GSM967852 GSM967853 GSM967854 GSM967855 GSM967856 GSM967862 GSM967863 GSM967864 GSM967865 GSM967857 GSM967858 GSM967859 GSM967860 GSM967861 7% 7% 8% 7% 7% 8% 7% 7% 7% 7% 7% 7% 11% 7% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM967852U87-EV human glioblastoma xenograft - Control 12.190837
GSM967853U87-EV human glioblastoma xenograft - Control 22.169197
GSM967854U87-EV human glioblastoma xenograft - Control 32.180178
GSM967855U87-EV human glioblastoma xenograft - Control 42.115457
GSM967856U87-EV human glioblastoma xenograft - Control 52.116777
GSM967862U87-EV human glioblastoma xenograft - Bevacizumab treated 12.22168
GSM967863U87-EV human glioblastoma xenograft - Bevacizumab treated 22.182537
GSM967864U87-EV human glioblastoma xenograft - Bevacizumab treated 32.145217
GSM967865U87-EV human glioblastoma xenograft - Bevacizumab treated 42.140677
GSM967857U87-EV human glioblastoma xenograft - dibenzazepine treated 12.158427
GSM967858U87-EV human glioblastoma xenograft - dibenzazepine treated 22.153637
GSM967859U87-EV human glioblastoma xenograft - dibenzazepine treated 32.138537
GSM967860U87-EV human glioblastoma xenograft - dibenzazepine treated 42.2723911
GSM967861U87-EV human glioblastoma xenograft - dibenzazepine treated 52.159647